The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Cyclin D1: polymorphism, aberrant splicing and cancer risk
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 1×
“The concept that RB is a critical downstream target of cyclin D1 was reinforced by study of the p16ink4a tumor suppressor. p16ink4a binds directly to CDK4 and CDK6 and displaces cyclin D1 from the complex (Serrano et al., 1993; Koh et al., 1995; Russo et al., 1998; Jeffrey et al., 2000).”
Backgroundβ-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Shapiro, M. B., & Senapathy, P. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.17.7155 · Cited by 2,275
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690 · cited 2×
“Disruption of this ‘p16-cyclin D1-RB’ axis is known to occur in the majority of human tumors (Palmero and Peters, 1996; Sherr and McCormick, 2002), thus underscoring the importance of this pathway in growth regulation.”
BackgroundA novel cyclin encoded by a bcl1-linked candidate oncogene
Motokura, T., Bloom, T., Kim, H. G., Jüppner., H., Ruderman, J. V., Kronenberg, H. M., & Arnold, A. (1991) · Nature · doi:10.1038/350512a0 · Cited by 1,265
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Fry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1427.3.11 · Cited by 1,236
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
D-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., & Weinberg, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90249-c · Cited by 995
Sherr, C. J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89005-2 · Cited by 980 · cited 4×
“From these beginnings, a wealth of studies systematically defined the manner in which cyclin D1 functions to regulate cell cycle and oncogenic transformation in mammalian cells (Sherr, 1995; Diehl, 2002; Gladden and Diehl, 2005).”
BackgroundInfluentialRetinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
Meyerson, M., & Harlow, E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2077 · Cited by 794
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746 · cited 1×
“Instability of the protein has been attributed to a C-terminal PEST sequence (Dragnev et al., 2001) and the presence of a specific GSK-3B phosphorylation site (threonine 286) (Diehl and Sherr, 1997; Diehl et al., 1997).”
BackgroundSelf-citationPhysical interaction of the retinoblastoma protein with human D cyclins
Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., & Weinberg, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90137-f · Cited by 744
Xiong, Y., Connolly, T., Futcher, B., & Beach, D. (1991) · Cell · doi:10.1016/0092-8674(91)90100-d · Cited by 685
Pocket proteins and cell cycle control
Cobrinik, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208619 · Cited by 601
Peuster, M., Wohlsein, P., Brügmann, M., Ehlerding, M., Seidler, K., Fink, C., Brauer, H., Fischer, A., & Hausdorf, G. (2001) · Heart · doi:10.1136/heart.86.5.563 · Cited by 569
Cyclin E and Survival in Patients with Breast Cancer
Keyomarsi, K., Tucker, S. L., Buchholz, T. A., Callister, M., Ding, Y., Hortobagyi, G. N., Bedrosian, I., Knickerbocker, C., Toyofuku, W., Lowe, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021153 · Cited by 557
Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma
Bergsagel, P. L., & Kuehl, W. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.021 · Cited by 556
Alt, J. R., Cleveland, J. L., Hannink, M., & Diehl, J. A. (2000) · Genes & Development · doi:10.1101/gad.854900 · Cited by 535
Self-citationRusso, A. A., Tong, L., Lee, J.-O., Jeffrey, P. D., & Pavletich, N. P. (1998) · Nature · doi:10.1038/26155 · Cited by 524
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E. (1995) · Nature · doi:10.1038/375506a0 · Cited by 516
Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6
Toogood, P. L., Harvey, P. J., Repine, J. T., Sheehan, D. J., VanderWel, S. N., Zhou, H., Keller, P. R., McNamara, D. J., Sherry, D., Zhu, T., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049354h · Cited by 513 · cited 1×
“CDK4/CDK6-specific small molecule inhibitors have been developed and one such molecule, PD 0332991, exhibits an IC50 in the nanomolar range, with excellent target specificity (Fry et al., 2004; Toogood et al., 2005).”
BackgroundCyclin D1 protein expression and function in human breast cancer
Bartkova, J., Lukas, J., Müller, H., Lützhøt, D., Strauss, M., & Bartek, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570311 · Cited by 509
Cycling to Cancer with Cyclin D1
Diehl, J. A. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.72 · Cited by 475
Self-citationLinking cyclins to transcriptional control
Coqueret, O. (2002) · Gene · doi:10.1016/s0378-1119(02)01055-7 · Cited by 431
A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer
Lamb, J., Ramaswamy, S., Ford, H. L., Contreras, B., Martinez, R. V., Kittrell, F. S., Zahnow, C. A., Patterson, N., Golub, T. R., & Ewen, M. E. (2003) · Cell · doi:10.1016/s0092-8674(03)00570-1 · Cited by 416
Agami, R., & Bernards, R. (2000) · Cell · doi:10.1016/s0092-8674(00)00010-6 · Cited by 390
Control of pRB phosphorylation
Mittnacht, S. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80057-9 · Cited by 389
Lukas, J., Bartkova, J., Rohde, M., Strauss, M., & Bartek, J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2600 · Cited by 366
Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element
Sabbah, M., Courilleau, D., Mester, J., & Redeuilh, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11217 · Cited by 365
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.
Jiang, W., Zhang, Y. J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R., & Weinstein, I. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9026 · Cited by 360
Emerging roles for E2F: Beyond the G1/S transition and DNA replication
Cam, H., & Dynlacht, B. D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00080-1 · Cited by 349
Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M., Villamor, N., Tassies, D., Jaffe, E., Montserrat, E., & Rozman, C. (1994) · Blood · doi:10.1182/blood.v84.8.2726.2726 · Cited by 345
Polymorphisms in DNA repair and metabolic genes in bladder cancer
Sanyal, S. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh058 · Cited by 339
Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1
Zwijsen, R. M. L., Buckle, R. S., Hijmans, E. M., Loomans, C. J. M., & Bernards, R. (1998) · Genes & Development · doi:10.1101/gad.12.22.3488 · Cited by 305
Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts.
Won, K. A., Xiong, Y., Beach, D., & Gilman, M. Z. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9910 · Cited by 272
Lukas, J., Müller, H., Bartkova, J., Spitkovsky, D., Kjerulff, A. A., Jansen-Dürr, P., Strauss, M., & Bartek, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.3.625 · Cited by 269
Amplification and Overexpression of Cyclin D1 in Human Hepatocellular Carcinoma
Zhang, Y. J., Jiang, W., Chen, C. J., Lee, C. S., Kahn, S. M., Santella, R. M., & Weinstein, I. B. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2350 · Cited by 241
Structural basis of inhibition of CDK–cyclin complexes by INK4 inhibitors
Jeffrey, P. D., Tong, L., & Pavletich, N. P. (2000) · Genes & Development · doi:10.1101/gad.851100 · Cited by 239
Cyclin D1 expression is regulated by the retinoblastoma protein.
Müller, H., Lukas, J., Schneider, A., Warthoe, P., Bartek, J., Eilers, M., & Strauss, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.2945 · Cited by 235
Wieringa, B., Meyer, F., Reiser, J., & Weissmann, C. (1983) · Nature · doi:10.1038/301038a0 · Cited by 223
Solomon, D. A., Wang, Y., Fox, S. R., Lambeck, T. C., Giesting, S., Lan, Z., Senderowicz, A. M., & Knudsen, E. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303969200 · Cited by 218
Self-citationTumor-Specific Proteolytic Processing of Cyclin E Generates Hyperactive Lower-Molecular-Weight Forms
Porter, D. C., Zhang, N., Danes, C., McGahren, M. J., Harwell, R. M., Faruki, S., & Keyomarsi, K. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6254-6269.2001 · Cited by 194
Reutens, A. T. (2001) · Molecular Endocrinology · doi:10.1210/me.15.5.797 · Cited by 189
Cyclin-dependent Kinases Phosphorylate Human Cdt1 and Induce Its Degradation
Liu, E., Li, X., Yan, F., Zhao, Q., & Wu, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300549200 · Cited by 188
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
McMahon, C., Suthiphongchai, T., DiRenzo, J., & Ewen, M. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5382 · Cited by 178
Diehl, J. A., & Sherr, C. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7362 · Cited by 173
Self-citationInoue, K., & Sherr, C. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1590 · Cited by 168
The activities of cyclin D1 that drive tumorigenesis
Ewen, M. E., & Lamb, J. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.02.005 · Cited by 162
Location, location, location: The role of cyclin D1 nuclear localization in cancer
Gladden, A. B., & Diehl, J. A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20613 · Cited by 154
Self-citationCyclin D1: Mechanism and Consequence of Androgen Receptor Co-repressor Activity
Petre, C. E., Wetherill, Y. B., Danielsen, M., & Knudsen, K. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106399200 · Cited by 144
Self-citationLin, S., Wang, W., Wilson, G. M., Yang, X., Brewer, G., Holbrook, N. J., & Gorospe, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.7903-7913.2000 · Cited by 140
Zheng, Y., Shen, H., Sturgis, E. M., Wang, L. E., Eicher, S. A., Strom, S. S., Frazier, M. L., Spitz, M. R., & Wei, Q. (2001) · Carcinogenesis · doi:10.1093/carcin/22.8.1195 · Cited by 139
Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer
Wang, L., Habuchi, T., Takahashi, T., Mitsumori, K., Kamoto, T., Kakehi, Y., Kakinuma, H., Sato, K., Nakamura, A., Ogawa, O., et al. (2002) · Carcinogenesis · doi:10.1093/carcin/23.2.257 · Cited by 137
Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3)
Pibiri, M., Ledda‐Columbano, G. M., Cossu, C., Simbula, G., Menegazzi, M., Shinozuka, H., & Columbano, A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0416com · Cited by 135
Cyclin D1 protein expression and gene polymorphism in colorectal cancer
McKay, J., Douglas, J. J., Ross, V. G., Curran, S., Murray, G. I., Cassidy, J., & Initiative, O. B. O. T. A. C. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001001)88:1<77::aid-ijc12>3.0.co;2-o · Cited by 130
Cyclin D1 Represses STAT3 Activation through a Cdk4-independent Mechanism
Bienvenu, F., Gascan, H., & Coqueret, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100795200 · Cited by 118
Regulation of Exit from Quiescence by p27 and Cyclin D1-CDK4
Ladha, M. H., Lee, K. Y., Upton, T. M., Reed, M. F., & Ewen, M. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6605 · Cited by 110
Regulation of the Functional Interaction between Cyclin D1 and the Estrogen Receptor
Lamb, J., Ladha, M. H., McMahon, C. M., Sutherland, R. L., & Ewen, M. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8667-8675.2000 · Cited by 108
Winston, J. T., & Pledger, W. J. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.11.1133 · Cited by 102
Porter, T. R., Richards, F. M., Houlston, R. S., Evans, D. G., Jankowski, J. A., MacDonald, F., Norbury, G., Payne, S. J., Fisher, S., Tomlinson, I. P. M., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205245 · Cited by 91
Cyclin D1 Represses the Basic Helix-Loop-Helix Transcription Factor, BETA2/NeuroD
Ratineau, C., Petry, M. W., Mutoh, H., & Leiter, A. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110747200 · Cited by 87
Cyclin D1 Polymorphism and Expression in Patients with Squamous Cell Carcinoma of the Head and Neck
Holley, S. L., Parkes, G., Matthias, C., Bockmühl, U., Jahnke, V., Leder, K., Strange, R. C., Fryer, A. A., & Hoban, P. R. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63038-6 · Cited by 87
Leng, X., Noble, M. E. M., Adams, P. D., Qin, J., & Harper, J. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2242-2254.2002 · Cited by 86
Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development
Lieubeau, B., Heymann, M., Henry, F., Barbieux, I., Méflah, K., & Gr�goire, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990517)81:4<616::aid-ijc18>3.0.co;2-s · Cited by 85
Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism
Wang, L., Habuchi, T., Mitsumori, K., Li, Z., Kamoto, T., Kinoshita, H., Tsuchiya, N., Sato, K., Οhyama, C., Nakamura, A., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10793 · Cited by 81
Kelley, M. J., Nakagawa, K., Steinberg, S., Mulshine, J. L., Kamb, A., & Johnson, B. E. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.756 · Cited by 80
Cyclin D1 Polymorphism and Increased Risk of Colorectal Cancer at Young Age
Kong, S., Wei, Q., Amos, C. I., Lynch, P. M., Levin, B., Zong, J., & Frazier, M. L. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1106 · Cited by 77
Burd, C. J., Petre, C. E., Moghadam, H., Wilson, E. M., & Knudsen, K. E. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0266 · Cited by 75
Self-citationA central domain of cyclin D1 mediates nuclear receptor corepressor activity
Petre, C. E., Williams, E., Burd, C. J., Gladden, A. B., Moghadam, H., Meller, J., Diehl, J. A., & Knudsen, K. E. (2004) · Oncogene · doi:10.1038/sj.onc.1208200 · Cited by 72
Self-citationInhibition of Smad Antiproliferative Function by CDK Phosphorylation
Liu, F., & Matsuura, I. (2004) · Cell Cycle · doi:10.4161/cc.4.1.1366 · Cited by 67
Hosokawa, Y., Gadd, M. A., Smith, A. P., Koerner, F. C., Schmidt, E. V., & Arnold, A. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04605-3 · Cited by 67
Association of Cyclin D1 Genotype with Breast Cancer Risk and Survival
Shu, X. O., Moore, D. B., Cai, Q., Cheng, J., Wen, W., Pierce, L. A., Cai, H., Gao, Y., & Zheng, W. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.91.14.1 · Cited by 63
Dufourny, B., van Teeffelen, H. A. A. M., Hamelers, I. H. L., Sussenbach, J. S., & Steenbergh, P. H. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660329 · Cited by 61
Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1
Zukerberg, L., Benedict, W. F., Arnold, A., Dyson, N. J., Harlow, E. E., & Harris, N. L. (1996) · Blood · doi:10.1182/blood.v88.1.268.268 · Cited by 59
Novel splice variants of cyclin E with altered substrate specificity
Porter, D. C., & Keyomarsi, K. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.23.e101 · Cited by 59
Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma
Casson, A. G., Zheng, Z., Evans, S. C., Geldenhuys, L., van Zanten, S. V., Veugelers, P. J., Porter, G. A., & Guernsey, D. L. (2005) · Cancer · doi:10.1002/cncr.21229 · Cited by 59
Phosphorylation of the retinoblastoma-related protein p130 in growth-arrested cells
Canhoto, A. J., Chestukhin, A., Litovchick, L., & DeCaprio, J. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203893 · Cited by 54
Polymorphisms in cyclin D1 gene and hepatocellular carcinoma
Zhang, Y., Chen, S., Chen, C., & Santella, R. M. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10028 · Cited by 50
Yi, H., Eu, K. W., Seow‐Choen, F., Fook-Chong, S. M. C., & Cheah, P. Y. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.01.009 · Cited by 49
The 870G>A Polymorphism of the Cyclin D1 Gene is not Associated with Breast Cancer
Krippl, P., Langsenlehner, U., Renner, W., Yazdani‐Biuki, B., Wolf, G. L., Wascher, T. C., Paulweber, B., Weitzer, W., Leithner, A., & Samonigg, H. (2003) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000004372.20461.33 · Cited by 47
Mumberg, D., Wick, M., Bürger, C., Haas, K., Funk, M., & Müller, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.11.2098 · Cited by 42
Cyclin Proteolysis as a Retinoid Cancer Prevention Mechanism
Dragnev, K. H., Freemantle, S. J., Spinella, M. J., & Dmitrovsky, E. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb02724.x · Cited by 42
Cited by
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767
Self-citationCyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
Somatic mutant clones colonize the human esophagus with age
Martincorena, I., Fowler, J. C., Wabik, A., Lawson, A. R. J., Abascal, F., Hall, M. W. J., Cagan, A., Murai, K., Mahbubani, K., Stratton, M. R., et al. (2018) · Science · doi:10.1126/science.aau3879 · Cited by 1,113
Alao, J. P. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-24 · Cited by 871
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 814
Metadata
- Authors
- Knudsen, K. E., Diehl, J. A., Haiman, C. A., & Knudsen, E. S.
- Venue
- Oncogene
- Published
- 2006-03-13
- Volume
- 25
- Issue
- 11
- Pages
- 1620-1628
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1983409515
- Cited by
- 363
- References
- 89
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.